Dose escalation with proton-beam boost for low-risk prostate cancer: Commentary

Nature Clinical Practice Urology

Volumn 3, Issue 5, 2006, Pages 256-257

  Trabulsi, Edouard J ^a   Valicenti, Richard K ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Biochemical failure; Conformal radiotherapy; Dose; Morbidity; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BIOCHEMISTRY; CANCER CONTROL; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; GASTROINTESTINAL DISEASE; GLEASON SCORE; HUMAN; MORBIDITY; PHOTON THERAPY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROTON THERAPY; RADIATION DOSE; RECTUM DISEASE; SHORT SURVEY; TREATMENT FAILURE; UROGENITAL TRACT DISEASE;

EID: 33646699313     PISSN: 17434270     EISSN: 17434289     Source Type: Journal    
DOI: 10.1038/ncpuro0477     Document Type: Short Survey

References (5)

1. Shipley WU et al. (1995) Advanced prostate cancer: The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys 32: 3-12
2. Pollack A et al. (2002) Prostate cancer radiation dose response: Results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53: 1097-1105
3. Valicenti R et al. (2000) Survival advantage from higher-dose radiation therapy for clinically localized prostate cancer treated on the Radiation Therapy Oncology Group trials. J Clin Oncol 18: 2740-2746
4. Kuban D et al. (2003) Hazards of dose escalation in prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 57: 1260-1268
5. de Crevoisier R et al. (2005) Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 62: 965-973